Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 64

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells

Zeng, Yan, Zhang, Xiaoying, Kang, Kang, Chen, Jidong, Wu, Zhiqin, Huang, Jinyong, Lu, Wenju, Chen, Yuqin, Zhang, Jie, Wang, Zhiwei, Zhai, Yujia, Qu, Junle, Ramchandran, Ramaswamy, Raj, J. Usha, Wang, Jian, Gou, Deming · 2016 · Scientific Reports

Abstract

There is growing evidence that microRNAs are implicated in pulmonary arterial hypertension (PAH), but underlying mechanisms remain elusive. Here, we identified that miR-223 was significantly downregulated in chronically hypoxic mouse and rat lungs, as well as in pulmonary artery and pulmonary artery smooth muscle cells (PASMC) exposed to hypoxia. Knockdown of miR-223 increased PASMC proliferation. In contrast, miR-223 overexpression abrogated cell proliferation, migration and stress fiber formation. Administering miR-223 agomir in vivo antagonized hypoxia-induced increase in pulmonary artery pressure and distal arteriole muscularization. RhoB, which was increased by hypoxia, was identified as one of the targets of miR-223. Overexpressed miR-223 suppressed RhoB and inhibited the consequent phosphorylation of myosin phosphatase target subunit (MYPT1) and the expression of myosin light chain of myosin II (MLC2), which was identified as another target of miR-223. Furthermore, serum miR-223 levels were decreased in female patients with PAH associated with congenital heart disease. Our study provides the first evidence that miR-223 can regulate PASMC proliferation, migration and actomyosin reorganization through its novel targets, RhoB and MLC2, resulting in vascular remodeling and the development of PAH. It also highlights miR-223 as a potential circulating biomarker and a small molecule drug for diagnosis and treatment of PAH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep24900

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 54

  1. Archer, S. L., Weir, E. K. & Wilkins, M. R. Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation 121, 2045–66 (2010). · DOI · Paper page
  2. Humbert, M. et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43, 13S–24S (2004). · DOI · Paper page
  3. Crosswhite, P. & Sun, Z. Molecular mechanisms of pulmonary arterial remodeling. Mol Med 20, 191–201 (2014). · DOI
  4. Heasman, S. J. & Ridley, A. J. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 9, 690–701 (2008). · DOI · Paper page
  5. Wojciak-Stothard, B. et al. Role of RhoB in the regulation of pulmonary endothelial and smooth muscle cell responses to hypoxia. Circ Res 110, 1423–34 (2012). · DOI
  6. Kajimoto, H. et al. Oxygen activates the Rho/Rho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction. Circulation 115, 1777–88 (2007). · DOI
  7. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116, 281–97 (2004). · DOI
  8. Dang, L. T., Lawson, N. D. & Fish, J. E. MicroRNA control of vascular endothelial growth factor signaling output during vascular development. Arterioscler Thromb Vasc Biol 33, 193–200 (2013). · DOI
  9. Davis, B. N., Hilyard, A. C., Lagna, G. & Hata, A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454, 56–61 (2008). · DOI · Paper page
  10. Sarkar, J. et al. MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol Lung Cell Mol Physiol 299, L861–71 (2010). · DOI · Paper page
  11. Courboulin, A. et al. Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 208, 535–48 (2011). · DOI · Paper page
  12. Rangrez, A. Y., Massy, Z. A., Metzinger-Le Meuth, V. & Metzinger, L. miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet 4, 197–205 (2011). · DOI · Paper page
  13. Kang, K. et al. MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells. J Biol Chem 288, 25414–27 (2013). · DOI
  14. Wang, D. et al. MicroRNA-124 controls the proliferative, migratory and inflammatory phenotype of pulmonary vascular fibroblasts. Circ Res 114, 67–78 (2014). · DOI · Paper page
  15. Tang, H., Ayon, R. J. & Yuan, J. X. New insights into the pathology of pulmonary hypertension: implication of the miR-210/ISCU1/2/Fe-S axis. EMBO Mol Med 7, 689–91 (2015). · DOI
  16. Chen, T. et al. Loss of microRNA-17 approximately 92 in smooth muscle cells attenuates experimental pulmonary hypertension via induction of PDZ and LIM domain 5. Am J Respir Crit Care Med 191, 678–92 (2015). · DOI
  17. Brock, M. et al. AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension. Eur Heart J 35, 3203–11 (2014). · DOI
  18. Parikh, V. N. et al. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation 125, 1520–32 (2012). · DOI · Paper page
  19. Lu, H., Buchan, R. J. & Cook, S. A. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc Res 86, 410–20 (2010). · DOI · Paper page
  20. Sun, W. et al. miR-223 and miR-142 attenuate hematopoietic cell proliferation and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-beta. Cell Res 20, 1158–69 (2010). · DOI
  21. Eyholzer, M. et al. Complexity of miR-223 regulation by CEBPA in human AML. Leuk Res 34, 672–6 (2010). · DOI
  22. Wong, Q. W. et al. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 135, 257–69 (2008). · DOI · Paper page
  23. Laios, A. et al. Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol Cancer 7, 35 (2008). · DOI · Paper page
  24. Greco, S. et al. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J 23, 3335–46 (2009). · DOI · Paper page
  25. Shi, L. et al. MicroRNA-223 antagonizes angiogenesis by targeting beta1 integrin and preventing growth factor signaling in endothelial cells. Circ Res 113, 1320–30 (2013). · DOI · Paper page
  26. Pietra, G. G. et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 43, 25S–32S (2004). · DOI · Paper page
  27. Chen, B., Calvert, A. E., Cui, H. & Nelin, L. D. Hypoxia promotes human pulmonary artery smooth muscle cell proliferation through induction of arginase. Am J Physiol Lung Cell Mol Physiol 297, L1151–9 (2009). · DOI
  28. Totsukawa, G. et al. Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J Cell Biol 150, 797–806 (2000). · DOI · Paper page
  29. Singh, D. K., Sarkar, J., Raghavan, A., Reddy, S. P. & Raj, J. U. Hypoxia modulates the expression of leucine zipper-positive MYPT1 and its interaction with protein kinase G and Rho kinases in pulmonary arterial smooth muscle cells. Pulm Circ 1, 487–98 (2011). · DOI
  30. Di Stefano, V., Zaccagnini, G., Capogrossi, M. C. & Martelli, F. microRNAs as peripheral blood biomarkers of cardiovascular disease. Vascul Pharmacol 55, 111–8 (2011). · DOI
  31. Wang, G. K. et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31, 659–66 (2010). · DOI · Paper page
  32. Wei, C. et al. Circulating miRNAs as potential marker for pulmonary hypertension. PLos One 8, e64396 (2013). · DOI
  33. Evans, A. M., Hardie, D. G., Peers, C. & Mahmoud, A. Hypoxic pulmonary vasoconstriction: mechanisms of oxygen-sensing. Curr Opin Anaesthesiol 24, 13–20 (2011). · DOI
  34. Hale, A. E., White, K. & Chan, S. Y. Hypoxamirs in Pulmonary Hypertension: Breathing New Life into Pulmonary Vascular Research. Cardiovasc Diagn Ther 2, 200–212 (2012).
  35. Caruso, P. et al. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol 30, 716–23 (2010). · DOI · Paper page
  36. Rangrez, A. Y. et al. Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223. PLos One 7, e47807 (2012). · DOI
  37. Meloche, J. et al. Role for DNA damage signaling in pulmonary arterial hypertension. Circulation 129, 786–97 (2014). · DOI · Paper page
  38. Meloche, J. et al. MiR-223 Reverses Experimental Pulmonary Arterial Hypertension. Am J Physiol Cell Physiol. ajpcell 00149 2015 (2015). · DOI
  39. Sun, G., Li, H. & Rossi, J. J. Sequence context outside the target region influences the effectiveness of miR-223 target sites in the RhoB 3′UTR. Nucleic Acids Res 38, 239–52 (2010). · DOI
  40. Raman, N. & Atkinson, S. J. Rho controls actin cytoskeletal assembly in renal epithelial cells during ATP depletion and recovery. Am J Physiol 276, C1312–24 (1999). · DOI
  41. Lu, Q., Longo, F. M., Zhou, H., Massa, S. M. & Chen, Y. H. Signaling through Rho GTPase pathway as viable drug target. Curr Med Chem 16, 1355–65 (2009). · DOI
  42. Ji, X. et al. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55, 1944–9 (2009). · DOI · Paper page
  43. Tanaka, M. et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLos One 4, e5532 (2009). · DOI · Paper page
  44. Chen, X., Liang, H., Zhang, J., Zen, K. & Zhang, C. Y. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 22, 125–32 (2012). · DOI · Paper page
  45. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105, 10513–8 (2008). · DOI · Paper page
  46. Zampetaki, A. et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107, 810–7 (2010). · DOI · Paper page
  47. Zampetaki, A. et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol 60, 290–9 (2012). · DOI · Paper page
  48. Zhang, Y. Y. et al. Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome. J Thromb Thrombolysis 38, 65–72 (2013). · DOI
  49. de Torres, J. P. et al. Gender differences in plasma biomarker levels in a cohort of COPD patients: a pilot study. PLos One 6, e16021 (2011). · DOI
  50. Ma, K. et al. Human lung microRNA profiling in pulmonary arterial hypertension secondary to congenital heart defect. Pediatr Pulmonol 50, 1214–23 (2015). · DOI
  51. Kang, K. et al. A novel real-time PCR assay of microRNAs using S-Poly(T), a specific oligo(dT) reverse transcription primer with excellent sensitivity and specificity. PLoS One 7, e48536 (2012). · DOI
  52. Niu, Y. et al. An improved method for detecting circulating microRNAs with S-Poly(T) Plus real-time PCR. Sci Rep 5, 15100 (2015). · DOI
  53. Gou, D. et al. miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia. Am J Physiol Lung Cell Mol Physiol 303, L682–91 (2012). · DOI
  54. Shimoda, L. A. & Semenza, G. L. Functional analysis of the role of hypoxia-inducible factor 1 in the pathogenesis of hypoxic pulmonary hypertension. Methods Enzymol 381, 121–9 (2004). · DOI

Cited by

See all 64

Metadata

Authors
Zeng, Y., Zhang, X., Kang, K., Chen, J., Wu, Z., Huang, J., Lu, W., Chen, Y., Zhang, J., Wang, Z., Zhai, Y., Qu, J., Ramchandran, R., Raj, J. U., Wang, J., & Gou, D.
Venue
Scientific Reports
Published
2016-04-28
Volume
6
Issue
1
ISSN
2045-2322
Cited by
64
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells. https://app.cochat.ai/papers/10.1038/srep24900
The paper
Zeng, Y., Zhang, X., Kang, K., Chen, J., Wu, Z., Huang, J., Lu, W., Chen, Y., Zhang, J., Wang, Z., Zhai, Y., Qu, J., Ramchandran, R., Raj, J. U., Wang, J., & Gou, D. (2016). MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells. Scientific Reports. https://doi.org/10.1038/srep24900

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.